Tuesday, January 14, 2020

FDA Approves Gadavist (gadobutrol) Contrast Agent for Use in Cardiac MR in Adult Patients with Known or Suspected Coronary Artery Disease

›
In continuation of my update on Gadavist (gadobutrol) Bayer announced today the U.S. Food and Drug Administration (FDA) has approved...
Monday, January 13, 2020

FDA Approves Nouress (cysteine hydrochloride) Injection for Treating Neonate Patients Requiring Total Parenteral Nutrition (TPN)

›
Avadel Pharmaceuticals plc (Nasdaq: AVDL) announced today that the U.S. Food and Drug Administration (FDA) has approved Nouress (A...
Saturday, January 11, 2020

FDA Approves Otezla (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease

›
In continuation of my update on  Otezla (apremilast)  Celgene Corporation today announced that the U.S. Food and Drug Administration...
Friday, January 10, 2020

FDA Approves Accrufer (ferric maltol) for the Treatment of Iron Deficiency in Adults

›
Shield Therapeutics plc (LSE: STX), a commercial stage, pharmaceutical company with a focus on addressing iron deficiency, announces tha...
Thursday, January 9, 2020

FDA Approves Nubeqa (darolutamide) for Men with Non-Metastatic Castration-Resistant Prostate Cancer

›
The U.S. Food and Drug Administration (FDA) today approved  Nubeqa  (darolutamide), an androgen receptor inhibitor (ARi), for the tr...
Wednesday, January 8, 2020

FDA Approves AirDuo Digihaler (fluticasone propionate and salmeterol) Inhalation Powder for Asthma

›
In continuation of my update on  (fluticasone propionate and salmeterol     Teva Pharmaceutical Industries Ltd. (NYSE and TASE...
Tuesday, January 7, 2020

Selinexor Offers Hope Against a Tough-to-Treat Blood Cancer

›
In continuation of my update on  Selinexor Patients with a form of blood cancer known as multiple myeloma who haven't responde...

FDA Approves Turalio (pexidartinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumors (TGCT) in Adults

›
U.S. Food and Drug Administration granted approval to Turalio (pexidartinib) capsules for the treatment of adult patients with symptom...
Sunday, January 5, 2020

FDA Approves Xpovio (selinexor) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma

›
In continuation of my update on Selinexor Karyopharm Therapeutics Inc. an oncology-focused pharmaceutical company, announced that ...
Saturday, January 4, 2020

FDA Approves Thiola EC (tiopronin) for the Treatment of Cystinuria

›
Retrophin, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved 100 mg and 300 mg tablets of Thiola EC (tiopronin)...
Tuesday, December 24, 2019

Ipsen Announces U.S. FDA Approval for Newly Designed Pre-Filled Syringe for Somatuline Depot (lanreotide)

›
  Ipsen Biopharmaceuticals, an affiliate of Ipsen , announced today that the United States Food and Drug Administration (FDA) has appr...
Monday, December 23, 2019

Dova Pharmaceuticals Announces FDA Approval of Doptelet (avatrombopag) for Treatment of Chronic Immune Thrombocytopenia (ITP)

›
In continuation of my update on avatrombopag Dova Pharmaceuticals, Inc.  a pharmaceutical company focused on acquiring, developi...
Saturday, December 21, 2019

Experimental Drug, Voxelotor, Shows Early Promise Against Sickle Cell Disease

›
An experimental drug for sickle cell disease reduced anemia and boosted the health of red blood cells in patients, according to a ...